(0.37%) 5 037.08 points
(0.39%) 38 051 points
(0.79%) 15 728 points
(0.03%) $79.02
(5.02%) $2.03
(0.06%) $2 312.50
(0.29%) $26.83
(0.84%) $962.95
(-0.05%) $0.933
(-0.18%) $11.01
(0.03%) $0.799
(-1.44%) $91.92
Live Chart Being Loaded With Signals
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally...
Stats | |
---|---|
Šios dienos apimtis | 164 726 |
Vidutinė apimtis | 503 952 |
Rinkos kapitalizacija | 2.42M |
EPS | $0 ( 2024-02-13 ) |
Kita pelno data | ( $-0.170 ) 2024-06-19 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.190 |
ATR14 | $0.00100 (0.65%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-29 | Trombly Amy Moss | Buy | 60 000 | Stock option (right to buy) |
2023-12-29 | Thornton Bruce | Buy | 60 000 | Stock option (right to buy) |
2023-12-29 | Dal Poggetto John | Buy | 50 000 | Stock option (right to buy) |
2023-12-29 | Dvonch Jerome J | Buy | 60 000 | Stock option (right to buy) |
2023-07-17 | Dal Poggetto John | Sell | 5 000 | Stock option (right to buy) |
INSIDER POWER |
---|
85.69 |
Last 96 transactions |
Buy: 1 783 187 | Sell: 474 451 |
Tūris Koreliacija
Sonoma Pharmaceuticals Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
USEG | 0.871 |
ISUN | 0.863 |
HOOK | 0.862 |
IONS | 0.837 |
GRAY | 0.836 |
TCRT | 0.835 |
PLXP | 0.832 |
PRSO | 0.831 |
LQDT | 0.83 |
NEPT | 0.829 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Sonoma Pharmaceuticals Koreliacija - Valiuta/Žaliavos
Sonoma Pharmaceuticals Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $13.27M |
Bruto pelnas: | $4.48M (33.73 %) |
EPS: | $-1.520 |
FY | 2023 |
Pajamos: | $13.27M |
Bruto pelnas: | $4.48M (33.73 %) |
EPS: | $-1.520 |
FY | 2022 |
Pajamos: | $12.63M |
Bruto pelnas: | $3.99M (31.62 %) |
EPS: | $-1.920 |
FY | 2021 |
Pajamos: | $18.63M |
Bruto pelnas: | $6.56M (35.21 %) |
EPS: | $-1.970 |
Financial Reports:
No articles found.
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a HOCl-based topical prescription product indicated to promote efficient healing through the management of new and old scars; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis. It also provides Acuicyn, a HOCl-based product indicated to relieve itch and inflammation while helping to keep areas around the eye clean; and Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a wide range of pathogens, as well as antibiotic-resistant strains that slow the natural healing of wounds. In addition, the company offers MicrocynAH, an HOCl-based solution designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin for healing; Microdacyn60 oral care solution for the treatment of mouth and throat infections; MucoClyns for the use in emergencies and safe to use on mucous membranes, cuts, abrasions, burns, and body surfaces; Endocyn root canal irrigation solutions; Pediacyn atopic dermatitis hydrogel; Ocucyn eyelid and eyelash cleanser; Gramaderm for the treatment of topical mild to moderate acne; Nanocyn, a hospital-grade disinfectant; and Sinudox for nasal irrigation. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Woodstock, Georgia.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.